The aim of this review is to analyze the role of NF-κB in this hematologic cancer, focusing on NF-κB-dependent mechanisms in tumor cells, MSCs and myeloma–mesenchymal stromal cell crosstalk. This evidence concerns the gene NFKB1 and hematopoietic and lymphoid cell neoplasm.